Sunday, December 16, 2007 2:26:57 PM
CELG - Celgene Corporation.
Celgene Corporation is a multinational integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. THALOMID (thalidomide) is its lead product, which is marketed for the treatment of erythema nodosum leprosum (ENL), but also used off-label for treating multiple myeloma and other cancers.
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
.
.
Celgene Corporation is a multinational integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. THALOMID (thalidomide) is its lead product, which is marketed for the treatment of erythema nodosum leprosum (ENL), but also used off-label for treating multiple myeloma and other cancers.
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
